View Article

  • Formulation And Evaluation of Gutika by Using Arjuna Extract for Antidiabetic Activity

  • Rungta Institute of Pharmaceutical Sciences and Research.

Abstract

The prevalence of diabetes mellitus, a chronic metabolic condition, is rising globally. It is frequently treated with traditional drugs that can have negative side effects. As a result, there is increasing interest in herbal substitutes that may have therapeutic advantages. A common Ayurvedic medicinal herb, Terminalia arjuna has antidiabetic, cardioprotective, and antioxidant qualities. The creation and assessment of Gutika (herbal tablets) containing Arjuna bark extract for the treatment of diabetes are the main objectives of this study. The presence of flavonoids, alkaloids, phenolics, and terpenoids was confirmed by phytochemical screening after the extract was made using the Soxhlet method with methanol as a solvent. Accurate active compound quantification was confirmed by a UV-visible spectrophotometric analysis at 375 nm. In order to maximize tablet characteristics, binders, fillers, and disintegrants were added to the manufactured tablets along with Arjuna extract. Physicochemical analyses of the tablets' hardness, friability, weight fluctuation, and disintegration time verified that they complied with accepted pharmaceutical standards. The results imply that Arjuna Gutika has potential as a natural substitute for diabetes treatment. To confirm its effectiveness and safety, more clinical and pharmacological research is required. In order to cure diabetes, this study supports the possible combination of contemporary pharmaceutical formulations with traditional herbal medicine.

Keywords

Diabetes mellitus, Terminalia arjuna, herbal medicine, Gutika, antidiabetic activity, phytochemical screening, Soxhlet extraction, Ayurvedic formulation, bioactive compounds, alternative medicine.

Introduction

Globally, diabetes is a serious health issue. The most common medications for diabetes are insulin and oral hypoglycemics, although they have a number of negative effects, including lactic acidosis, weight gain, hypoglycemia, and significant harm to the kidneys and liver. The medical system still faces the issue of managing diabetes without causing adverse effects. Demand for using natural products with anti-diabetic properties is rising. Herbal medicine has expanded dramatically in recent years, and both developed and developing countries are increasingly using these drugs because of their natural origin and few adverse effects. The big tropical woody tree known as Arjuna (Terminalia arjuna) is found all over India. This tree, which is between 20 and 25 meters tall, usually has a buttressed trunk, and at the crown, it creates a broad canopy from which branches hang down. The composition the essential drug list of India's ayurvedic formulary includes the Herbo mineral formulation Terminalia Arjuna gutika/vati. This age-old Ayurvedic treatment has been used for centuries to treat liver diseases, skin disorders, and jaundice. It is regarded to be effective and safe. Leprosy, fever, oedema, obesity, jaundice, and other liver issues are treated with it. The list of ingredients for Arjuna gutika is as follows. It is known that several ingredients in Arjuna Vati, including Terminalia Arjuna, Hari Taki, Stevia leaves, Acacia gum, and Guggul, have hypo-lipidemic qualities. Ayurvedic doctors in various parts of India have long recommended this combination for its antidiabetic properties, however there is no written proof of its impact on lowering blood sugar levels. As a result, it was chosen to assess its antidiabetic properties. The study found that oral administration of T. arjuna at 250 and 500 mg/kg body weight for 30 days significantly reduced blood glucose levels. In comparison with control rats, diabetic rats showed significantly higher aldolase activity and significantly lower hero kinase and phosphor-gluco-isomerase activity. These levels were markedly restored to normal after 30 days of oral T. arjuna 500 mg/kg body weight. Compared to diabetic control, the administration of T. arjuna bark extract significantly decreased the blood glucose level. The extract at 500 mg/kg body weight demonstrated a larger decrease in glucose levels than at 250 mg/kg body weight. The process could involve stimulating b-cells to secrete more insulin, which would increase the amount of glucose used by different tissues. In South and Central India, as well as in Uttar Pradesh, Madhya Pradesh, and West Bengal, arjunas are typically found growing on riverbanks or next to dry river beds. Tannins, triterpenoid saponins, flavonoids, gallic acids, ellagic acid, and phytosterol are the primary chemical components of arjuna. Arjuna is utilized not only as a heart tonic but also to treat a variety of conditions, including hypertension, liver cirrhosis, pulmonary TB, uterine disorders, venereal illness, epilepsy, chronic fever, nausea, diarrhea, dysentery, urticarial, ulcers, fractured bones, and diuresis. In Ayurveda, T. arjuna bark is used to treat diabetes. Arjuna affects the human body's numerous physiological systems in a variety of ways.

MATERIALS AND METHODS

Plant Materials:

 

S. no

Plant / Materials

Supplier

Figure

1

Arjuna Bark

Jain Lifesciences (pvt) Ltd. 54/B2 IDA, Kattedan, Hyderabad- 500077. (Telangana). INDIA.

2

Guggul

AJ AGRI EXPORTS® 41-D, Bunglow No.58, station road, neemuch (458-441) M.P. India.

3

Acacia gum

Forest found agro products, first floor, plot no 301, puranbag India, kasanagar, Katargam, Surat, 395004, Lice. No.10020021005825.

4

Haritaki

HNCO organics Pvt. Ltd 56/A, Sumel-5, Asarwa, Ahmedabad, India 380016 mfg. license number GA/713-A.

5

Stevia leaves

NUTRIZO advancis healthcare PVT. LTD.

6

Coconut oil

E-Mox manufacturing private limited, Puducherry, 605111.Lic. No.10014045000068

Extraction Method: The T. arjuna stem barks were carefully water washed after being cut into tiny pieces. The fresh barks were cleaned, allowed to air dry, and then baked at 40°C to finish drying. The dried barks arethen grinded to make powder, which were then screened to get fine powder. The process of extracting chemicals that are heat-labile. The Soxhlet apparatus is filled with a thimble composed of filter paper containing the powdered solid substance, arjuna bark powder. The device is connected to a reflux condenser and a round-bottomed flask filled with the solvent methanol. After the solvent in the Round Bottom flask is gently boiled in 40°C set in 48 hours, the vapor rises via the side tube, condenses in the condenser, and then descends into the thimble holding the arjuna bark material, gradually filling the Soxhlet. The part of the material that has been extracted is removed when the solvent, methanol, syphons over into the flask when it reaches the top of the connected tube. Until full extraction is accomplished, the process is repeated. After the extract was filtered and distilled on a water bath, a reddish-brown syrupy mass was produced. It was then dried in a rotary evaporator at a low temperature and with less pressure. 

                     

Fig.no: 1 (Extraction of Gutika)

Phytochemical Test:

Table No: 1 Phytochemical Test.

Phytochemical Test

T. Arjuna Methanol Extract

Phenolic

Positive

Terpenoids

Positive

Alkaloids

Positive

Flavonoids

Positive

Pre-Formulation Test:

  1. Solubility:
  • Water soluble: To ascertain whether arjuna extract is appropriate for aqueous formulations, it is tested for solubility in water.
  • Ethanol soluble: The More efficient solvents for removing a variety of bioactive substances, such as flavonoids and other ethanol-soluble substances found in arjuna bark may dissolve in ethanol.
  • Methanol soluble: methanol are organic solvents that can also be utilized to extract different bioactive substances from Arjuna bark may dissolve in methanol.

                                                   

Fig. no: 2 (Solubility)

  1. PH Test: The acidity or alkalinity of Terminalia arjuna extract is assessed by measuring its ph.  The extract's low acidity, indicated by its pH of about 5.5, is essential for stability and formulation compatibility.

Fig. no: 3 (pH test)

  1. Ash Value: the Ash Value The amount of inorganic residues, such as minerals and contaminants, is indicated by the total ash content.  To find the proportion of ash, the extract is heated to a high temperature (100°C) in a muffle furnace.

Fig. no: 4 (Ash Value)

  • Acid Insoluble Ash: Indicates non-digestible inorganic materials and is the portion of ash that does not dissolve after being treated with hydrochloric acid.
  • Water Soluble: Water soluble ash is the percentage of ash that dissolves in water; it is the difference between acid-insoluble ash and total ash.

Fig.no: 5 (Acid insoluble ash and Water soluble of Ash Extract)

  1. Standard calibration curve of Terminalia arjuna extract: The standard calibration curve of Terminalia arjuna extract is established using UV-Visible Spectrophotometry at a maximum wavelength (λmax) of 375 nm.  This approach follows Beer-Lambert's Law, which stipulates that the absorbance of a solution is directly proportional to its concentration.  The absorbance readings of a number of standard solutions with established concentrations—1, 2, 3, 4, and 5 µg/mL—are measured.  A linear connection is confirmed by the data, which consistently indicates an increase in absorbance with increasing concentration.  By comparing absorbance values to the standard curve, this calibration curve can be used as a guide to estimate the concentration of unknown samples.  The outcomes ensure that Terminalia arjuna extract is accurately formulated in pharmaceutical and herbal products by aiding in the quantitative estimate of its bioactive components.

Table no: 2 (Standard calibration curve of T. arjuna extract.)

Concentration (µg/ ml)

Wave Length

Absorbance

1

358nm

0.489

2

364nm

0.907

3

367nm

1.333

4

370nm

1.347

5

375nm

2.476

                                 

Fig. no: 6 (Standard calibration curve of Terminalia arjuna extract)

Graph no. 1: Standard calibration curve of Terminalia arjuna extract.

Formulation of Gutika:

Table no: 3 (Ingredient table of Gutika)

Ingredient

Quantity

Purpose

Arjuna Extract

300mg

Main active Ingredient

Guggul

100mg

Binder and regulate cholestrol

Haritaki

50mg

Filler and Digestive aid

Acacia Gum

25mg

Binding agent

Stevia Leaves

20mg

Natural Sweetner

Coconut Oil

5mg

Lubricant and Bioavailability enhancer

 Procedure of Gutika:

  • The normal dosage could be as much as 350 milligrams of extracts each pill.  Binders, fillers, and stabilizers are examples of excipients.  Binders: Guggul and other substances are frequently used to bind the extract and other excipients.  Fillers: Haritaki are used to give the tablet more volume.  Acacia gum is one of the disintegrants that aid in the release of its active ingredients.  Coconut oil is used as a lubricant.

                                 

Fig. no: 7 (Weight all Ingredient)

  • Combine the powder or extract Arjuna bark if using extract, remove excess moisture to bring it down to a semi-solid consistency.  If using powder, mix it in the appropriate amount with the base material or powdered excipients.  Add the excipients and binder:  To the powder, add a suitable binder (guggul), such as acacia gum, stevia leaves, haritaki, or coconut oil.  To get a uniform dough-like consistency, thoroughly mix.

Fig. no: 8 (Mix the all Ingredient)

  • Form into tablet: After the mixture has been well mixed, form it into tiny tablets using a table compression machine. Depending on the required dosage, each Gutika's weight and size can be adjusted.

       

Fig. no: 9 (Gutika Compression)                      Fig. no: 10 (Arjuna Extract Gutika)

Evaluation test of Gutika:

  1. Hardness Test: The standard acceptable range for hardness is 3.5 kg a lower observed value of 0.5 kg indicates that the tablet is softer than required, which may result in breakage during handling. Hardness Test A tablet's mechanical strength and resistance to breakage during handling, packaging, and transportation are determined by its hardness.

Fig. no: 11 (Hardness of Gutika)

  1. Weight Uniformity: Weight Uniformity by ensuring that each tablet has the appropriate quantity of excipients and active components, this test lowers batch variability.  There is a little but manageable weight fluctuation between the observed value of 490 mg ±2% and the normal weight of 500 mg ±5%.

                                 

Fig. No: 12 (Uniformity Weight Of Gutika)

  1. Time of Disintegration: The amount of time it takes for a pill to disintegrate into smaller pieces in the digestive tract is known as the disintegration time.  The observed time was 12 minutes, although the typical time is 15 minutes. This suggests that the pill disintegrates a little quicker than anticipated, which could affect the release of the medicine.

                                     

Fig. no: 13 (Disintegration time of Gutika)

  1. Loss of Drying (LOD):  The tablet's moisture content is determined by this test.  Stability and inhibition of microbiological growth are guaranteed by a specified limit of 1-3%.  The observed value of 1.09% indicates that the pill has dried properly because it falls within the allowed range.  Weight Variation Another crucial test for evaluating batch-to-batch consistency is weight variation.  The observed result is 490 mg ±2%, which shows a slight variance within acceptable ranges, compared to the normal weight of 500 mg ±5%.

Fig. no: 14 (Loss of drying of Gutika)

  1. Weight Variation: test guarantees that the prescribed dosage of medication is present in every pill in a batch.  The weight variation is computed when a predetermined number of pills are weighed.  The weight variation should stay within pharmacopeial bounds if the active component is evenly distributed.

Fig. no:15 (Weight Variation of Gutika)

Result: The study’s results indicate that while several quality parameters of the Gutika formulation meet acceptable standards, some aspects require improvement. The phytochemical screening of the Terminalia arjuna methanol extract confirmed the presence of phenolics, terpenoids, alkaloids, and flavonoids, and a standard calibration curve was successfully developed using UV-Visible spectrophotometry at a λmax of 375 nm.

Table no: 4 (Phytochemical test)

Phytochemical Test

T. Arjuna Methanol Extract

Phenolic

Positive

Terpenoids

Positive

Alkaloids

Positive

Flavonoids

Positive

Table no: 5 (Standard calibration curve of T. arjuna extract)

Concentration (µg/ ml)

Wave Length

Absorbance

1

358nm

0.489

2

364nm

0.907

3

367nm

1.333

5

375nm

2.476

Table no: 5 (Evaluation test of Gutika)

Test

Standard

Observation

Hardness test of Gutika

3.5 kg

0.5 kg

Uniformity Weight of Gutika

500mg±5%

490mg±2%

Disintegration time of Gutika

30 minutes

14 minutes

Loss of Drying of Gutika

1-3%

1.09%

Weight Variation of Gutika

500 mg±5%

490mg±2%

CONCLUSION: In conclusion, the formulated Gutika satisfied common pharmaceutical assessment standards and demonstrated good physicochemical characteristics.  Because of its capacity to enhance glucose metabolism and promote insulin production, the extract demonstrated strong antidiabetic effects.  Future research should concentrate on improving tablet hardness and carrying out clinical trials to verify Gutika's effectiveness and safety in human participants.

DISCUSSION: Gutika’s formulation and antidiabetic activity assessment employing Terminalia arjuna extract showed encouraging outcomes.  The presence of bioactive substances such phenolics, flavonoids, terpenoids, and alkaloids—all of which are known to support the therapeutic effects of medicinal plants—was verified by the phytochemical screening.  In terms of hardness, weight uniformity, disintegration time, and moisture content, the examination of Gutika produced positive findings, indicating that the prepared tablets satisfy the necessary pharmaceutical criteria.  Prior research showed that T. arjuna extract significantly lowered blood glucose levels, demonstrating its antidiabetic potential.  The stimulation of the pancreatic β-cells, which results in increased insulin secretion and improved glucose metabolism, may be the cause of this hypoglycemic effect. T. arjuna extract provides a natural substitute with fewer adverse effects than traditional synthetic antidiabetic medications.  To confirm these results and pinpoint the exact mechanism of action, more in vivo and clinical research is required.  Overall, the study backs up T. arjuna's traditional use in diabetes management and emphasizes how it could be included to standardized herbal formulations for safer and more efficient diabetic care.

ACKNOWLEDGE: I sincerely express my gratitude to Anjali Ma'am, Assistant Professor at Rungta Institute of Pharmaceutical Sciences and Research, for her invaluable guidance, constant encouragement, and insightful advice throughout this research. Her expertise and support have been instrumental in shaping the direction of this work. I deeply appreciate her time, patience, and constructive feedback, which have significantly contributed to the successful completion of this study.

REFERENCES

        1. Ragavan, B., And S. Krishnakumari. "Antidiabetic effect of T. Arjuna bark extract in alloxan induced diabetic rats." Indian journal of clinical biochemistry 21 (2006): 123-128.
        2. Biswas, Moulisha, et al. "Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats." Pharmaceutical biology 49.4 (2011): 335-340.
        3. Morshed, M. Alam, et al. "Anti-hyperglycemic and lipid lowering effect of Terminalia arjuna Bark extract on Streptozotocin induced Type-2 Diabetic Model Rats." International Journal of Pharmacy and Pharmaceutical Sciences 3.4 (2011): 450-454.
        4. Kumar, Chandan, Raj Kumar, and Shamshun Nehar. "Phytochemical properties, total antioxidant status of acetone and methanol extract of Terminalia arjuna Roxb. bark and its hypoglycemic effect on Type-II diabetic albino rats." Journal of Pharmacognosy and Phytochemistry 2.1 (2013).
        5. Gupta, Amit, and Sushama R. Chaphalkar. "Haemolytic activities and anti-diabetic effect of Terminalia arjuna and Emblica officinalis." Eur J Pharmac Med Res 3.6 (2016): 334-338.
        6. Patel, D. K., et al., "Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity." Asian Pacific Journal of Tropical Biomedicine 2.5 (2012): 411-420.
        7. Singh, Shikha, et al. "Evaluation of anti-diabetic activity of terminalia arjuna root extract in alloxan induced diabetic rats." Journal of Biomedical and Pharmaceutical Research 8.1 (2019): 20-29.
        8. Khatkar, Sarita, Arun Nanda, and S. H. Ansari. "Extraction, HPTLC Estimation, In silico and In vitro Evaluation of α-Amylase Inhibition Potential of Stem Bark of Terminalia arjuna." Current Biomarkers (Formerly: Recent Patents on Biomarkers) 6.1 (2016): 47-53.
        9. Parveen, kehkashan, parveen khan, and waseem a siddiqui. "Antidiabetic effects afforded by terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats." International journal of diabetes and metabolism 19.1 (2011): 23-33.
        10. Aamir, Khurram, et al. "Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide-induced type 2 diabetic rats." Life Sciences 289 (2022): 120232.
        11. Tafesse, Tadesse Bekele, et al. "Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice." BMC complementary and alternative medicine 17 (2017): 1-9.
        12. Kumar, Vikas, et al., "Therapeutic potential and industrial applications of Terminalia arjuna bark." Journal of Ethnopharmacology 310 (2023): 116352.
        13. Gurjar, Himanshu PS, Raghuveer Irchhaiya, and Amita Vermas. "Review on some medicinal plants with antidiabetic activity." Journal of Drug Delivery and Therapeutics 6.2 (2016): 45-51.
        14. Benalla, Wafaa, Said Bellahcen, and Mohamed Bnouham. "Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors." Current diabetes reviews 6.4 (2010): 247-254.
        15. Chattopadhyay, Kaushik, et al., "Effectiveness and safety of Ayurvedic medicines in type 2 diabetes mellitus management: a systematic review and meta-analysis." Frontiers in Pharmacology 13 (2022): 821810.
        16. Swain, Rupak K., et al., "A Study on Phytochemical and Pharmacological Activity of Terminalia arjuna: A Review." Research Journal of Pharmacognosy and Phytochemistry 2 (2023): 111-117.
        17. Sathyamurthy, Balasubramanian, B. Ranjitha, and Dinesh Bhaskar. "Invitro studies on the effect of Terminalia arjuna in adipocyte 3T3-L1 cell lines." PharmaTutor8 (2018): 17-26.

Reference

  1. Ragavan, B., And S. Krishnakumari. "Antidiabetic effect of T. Arjuna bark extract in alloxan induced diabetic rats." Indian journal of clinical biochemistry 21 (2006): 123-128.
  2. Biswas, Moulisha, et al. "Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats." Pharmaceutical biology 49.4 (2011): 335-340.
  3. Morshed, M. Alam, et al. "Anti-hyperglycemic and lipid lowering effect of Terminalia arjuna Bark extract on Streptozotocin induced Type-2 Diabetic Model Rats." International Journal of Pharmacy and Pharmaceutical Sciences 3.4 (2011): 450-454.
  4. Kumar, Chandan, Raj Kumar, and Shamshun Nehar. "Phytochemical properties, total antioxidant status of acetone and methanol extract of Terminalia arjuna Roxb. bark and its hypoglycemic effect on Type-II diabetic albino rats." Journal of Pharmacognosy and Phytochemistry 2.1 (2013).
  5. Gupta, Amit, and Sushama R. Chaphalkar. "Haemolytic activities and anti-diabetic effect of Terminalia arjuna and Emblica officinalis." Eur J Pharmac Med Res 3.6 (2016): 334-338.
  6. Patel, D. K., et al., "Diabetes mellitus: an overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity." Asian Pacific Journal of Tropical Biomedicine 2.5 (2012): 411-420.
  7. Singh, Shikha, et al. "Evaluation of anti-diabetic activity of terminalia arjuna root extract in alloxan induced diabetic rats." Journal of Biomedical and Pharmaceutical Research 8.1 (2019): 20-29.
  8. Khatkar, Sarita, Arun Nanda, and S. H. Ansari. "Extraction, HPTLC Estimation, In silico and In vitro Evaluation of α-Amylase Inhibition Potential of Stem Bark of Terminalia arjuna." Current Biomarkers (Formerly: Recent Patents on Biomarkers) 6.1 (2016): 47-53.
  9. Parveen, kehkashan, parveen khan, and waseem a siddiqui. "Antidiabetic effects afforded by terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats." International journal of diabetes and metabolism 19.1 (2011): 23-33.
  10. Aamir, Khurram, et al. "Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide-induced type 2 diabetic rats." Life Sciences 289 (2022): 120232.
  11. Tafesse, Tadesse Bekele, et al. "Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice." BMC complementary and alternative medicine 17 (2017): 1-9.
  12. Kumar, Vikas, et al., "Therapeutic potential and industrial applications of Terminalia arjuna bark." Journal of Ethnopharmacology 310 (2023): 116352.
  13. Gurjar, Himanshu PS, Raghuveer Irchhaiya, and Amita Vermas. "Review on some medicinal plants with antidiabetic activity." Journal of Drug Delivery and Therapeutics 6.2 (2016): 45-51.
  14. Benalla, Wafaa, Said Bellahcen, and Mohamed Bnouham. "Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors." Current diabetes reviews 6.4 (2010): 247-254.
  15. Chattopadhyay, Kaushik, et al., "Effectiveness and safety of Ayurvedic medicines in type 2 diabetes mellitus management: a systematic review and meta-analysis." Frontiers in Pharmacology 13 (2022): 821810.
  16. Swain, Rupak K., et al., "A Study on Phytochemical and Pharmacological Activity of Terminalia arjuna: A Review." Research Journal of Pharmacognosy and Phytochemistry 2 (2023): 111-117.
  17. Sathyamurthy, Balasubramanian, B. Ranjitha, and Dinesh Bhaskar. "Invitro studies on the effect of Terminalia arjuna in adipocyte 3T3-L1 cell lines." PharmaTutor8 (2018): 17-26.

Photo
Tanu Engle
Corresponding author

Rungta Institute of Pharmaceutical Sciences and Research.

Photo
Anjali
Co-author

Rungta Institute of Pharmaceutical Sciences and Research.

Tanu Engle*, Anjali, Formulation and Evaluation of Gutika by Using Arjuna Extract for Antidiabetic Activity, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 4, 1222-1234 https://doi.org/10.5281/zenodo.15188402

More related articles
Formulation And Evaluation Of Herbal Hair Serum...
Sruthi T P, N L Gowrishankar, Arshad A, Ayshafery K, Hasnath K, N...
Innovative and Alternative Approaches to Urticaria...
Krunal K. Detholia, Mukesh B. Jadeja, Umang R. Varia, Hitesh B. K...
Analysis of Bioactive Compounds in Indigenous Mush...
Pathan S. M., Pendbhaje N. S., Gaikwad D. S., Gondkar R. S., Gayk...
Project Review on Synthesis of Analgesic, Antioxidant Herbal Medicine...
Siddhi Jadhav, Harshada Dhangar, Swati Wakchoure, Harsh adhav, Shubhangi Kedar, ...
An Overview of Pharmacological Models and Phytoconstituents for The Anti-Inflamm...
Anjali Patil, Vikas Dhole, Dr. Sanganna Burli, Prashant Kumbhar, ...
Evaluation Of In-vivo Diuretic and In-vitro Litholytic Potential by Compound Eth...
Azhar Sulthana I., Suresh Kumar J., Mohan D., Naga Jyothi T., Sravani M., Smati K., ...
Related Articles
Formulation and Evaluation of Polyherbal Gel...
Megha Patel, Vishal Chudasama, Kiran Suthar, Bharat Rajpurohit, ...
Natural and Herbal Approaches to Hypertension Management: A Review of Transderma...
Dhanush S, Santhosh Kumar R, Subalakshmi G, Deepa R, ...
A Review On Diabetes Mellitus With Ketoacidosis...
Juveria, Dr. A. Srinivas Rao, Dr. AV Kishore Babu, ...
Formulation and Evaluation Herbal Wound Healing Ointment ...
Kavita Sharma, Tejas Anarthe, Rushikesh Wakalkar, ...
Formulation And Evaluation Of Herbal Hair Serum...
Sruthi T P, N L Gowrishankar, Arshad A, Ayshafery K, Hasnath K, Neha Siyan, ...
More related articles
Formulation And Evaluation Of Herbal Hair Serum...
Sruthi T P, N L Gowrishankar, Arshad A, Ayshafery K, Hasnath K, Neha Siyan, ...
Innovative and Alternative Approaches to Urticaria Management...
Krunal K. Detholia, Mukesh B. Jadeja, Umang R. Varia, Hitesh B. Katariya, Vidhi D. Panchal, Vishal B...
Analysis of Bioactive Compounds in Indigenous Mushrooms for Neurodegenerative Tr...
Pathan S. M., Pendbhaje N. S., Gaikwad D. S., Gondkar R. S., Gayke S. A., ...
Formulation And Evaluation Of Herbal Hair Serum...
Sruthi T P, N L Gowrishankar, Arshad A, Ayshafery K, Hasnath K, Neha Siyan, ...
Innovative and Alternative Approaches to Urticaria Management...
Krunal K. Detholia, Mukesh B. Jadeja, Umang R. Varia, Hitesh B. Katariya, Vidhi D. Panchal, Vishal B...
Analysis of Bioactive Compounds in Indigenous Mushrooms for Neurodegenerative Tr...
Pathan S. M., Pendbhaje N. S., Gaikwad D. S., Gondkar R. S., Gayke S. A., ...